Biotech

All Articles

Biogen bows out Denali Alzheimer's collab

.Biogen has returned civil rights to a very early Alzheimer's health condition program to Denali Reh...

Takeda faucets brand new head people oncology service-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Vertex, hammered by AATD once again, goes down 2 assets on dispose of pile

.Tip's attempt to address an uncommon genetic ailment has struck an additional obstacle. The biotech...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of personnel

.Vir Medical's second-quarter revenues file had not been short of big updates. The provider welcomed...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism situation

.Galapagos has stopped briefly application in a trial of a BCMA-directed CAR-T tissue therapy, pushi...

James Wilson leaving Penn to release pair of brand-new biotechs

.After much more than thirty years, genetics therapy trendsetter James Wilson M.D., Ph.D., is leavin...

3 biotechs attempt to beat the summer months warmth through losing team

.As biotechs attempt to transform a new web page in August, a minimum of three companies have lost s...

venBio elevates $528M for fifth lifestyle scientific researches VC fund

.Professional venture capital agency venBio has elevated an additional half a billion dollars to pur...

Otsuka pays $800M for Jnana and its own clinical-stage PKU medicine

.Otsuka Drug has grabbed Boston-based Jnana Rehabs for $800 million so the Japanese biotech can acqu...

FibroGen gives up 75% people team as asset fails 2 more tests

.FibroGen is radically restructuring its service, giving up 75% of its own U.S. staff as well as sto...